Clinical Trials Logo

Onychomycosis clinical trials

View clinical trials related to Onychomycosis.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06417983 Not yet recruiting - Fungal Infection Clinical Trials

Topical Application of Essential Oils to Treat Onchomycosis

NailFungus
Start date: May 30, 2024
Phase:
Study type: Observational

Patients with documented onychomycosis of one or more toe nails will be treated with a daily application of a topical lacquer containing several essential oils.

NCT ID: NCT06327295 Not yet recruiting - Onychomycosis Clinical Trials

A Study of ATB1651 in Adults With Mild to Moderate Onchomycosis

Start date: March 30, 2024
Phase: Phase 2
Study type: Interventional

The study is designed to evaluate the Safety, Tolerability and Pharmacokinetics of ATB1651 in participants with mild to moderate onychomycosis

NCT ID: NCT06254027 Not yet recruiting - Onychomycosis Clinical Trials

Clinical Investigation for the Evaluation of Efficacy and Safety of Two Medical Devices for Onychomycosis Treatment

Start date: March 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the effectiveness of FORTE, ACTIVE COVER LIGHT and Loceryl® in the treatment of onychomycosis based on the blinded evaluation of the percentage of healthy nail surface compared to baseline.

NCT ID: NCT06175013 Not yet recruiting - Onychomycosis Clinical Trials

Evaluation of a Combination of Two Medical Devices and One Device Use in the Treatment of Toenail Onychomycosis

Start date: June 2024
Phase: N/A
Study type: Interventional

The goal of this clinical investigation is to evaluate the efficacy of the tested products in medium to moderate onychomycosis after 112 days of treatments. The main question it aims to answer is the effectiveness of the use of a combination of two investigational devices (Sérum PURIFIANT + Sérum BOOSTER) on the percentage of healthy nail surface after 112 days of treatment. Participants will apply one or two devices on the affected toenail during the study. - Patients included on the groupe 1 will use Sérum PURIFIANT only, twice daily. - Patient included on group 2 will use Sérum PURIFIANT, twice daily associated with Sérum BOOSTER twice weekly. For this investigation, 44 patients (22 patients per group) presenting at least one infected toenail will be included to reach this objective.

NCT ID: NCT05809297 Not yet recruiting - Onychomycosis Clinical Trials

Diode Laser and Photodynamic Therapy Vs. Ciclopirox.

Laser
Start date: September 1, 2023
Phase: Phase 4
Study type: Interventional

The main objective of this study is to compare the efficacy of treatment of onychomycosis by: diode laser combined with photodynamic therapy, and topical treatment with Ciclopirox Hydroxypropyl Chitosan (HPCH) Nail Lacquer. The study is a low-intervention, randomised controlled clinical trial. Patient recruitment will be done by including in the sample those patients who have diagnostic confirmation of onychomycosis in the Chiropodology and Surgery Service of the University Podiatry Clinic of the Complutense University of Madrid. Participants in the trial will be assigned with equal probability to each treatment arm, according to their consecutive inclusion in the study. Subsequently, treatment assignment will be determined by a random code. The treatment used will be evident to both the participant and the podiatrist responsible for the intervention. Visits will be made every 7 days at the start of treatment and for 9 weeks in group 1 (treatment with laser and photodynamic therapy), and monthly visits in group 2 (treatment with ciclopirox nail polish) during the 12 months of follow-up. Regardless of the follow-up week at which healing occurs, all patients will be reviewed at 3, 6, 9 and 12 months after the first visit.

NCT ID: NCT05415852 Not yet recruiting - Onychomycosis Clinical Trials

Lasers in Onychomycosis

Start date: June 25, 2022
Phase: N/A
Study type: Interventional

Onychomycosis is the most common nail disease, representing more than 50% of all onychopathies. Future studies on the absorption spectra of dermatophyte fungi will be needed to develop lasers that effectively exploit absorption differences in fungi and dermal tissue.

NCT ID: NCT05390190 Not yet recruiting - Onychomycosis Clinical Trials

Radiofrequency in Onychomycosis

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

Onychomycosis is the most common nail disease, representing more than 50% of all onychopathies.

NCT ID: NCT05128916 Not yet recruiting - Clinical trials for Platelet Rich Plasma

Efficacy of Intralesional PRP in Treatment of Onychomycosis

Start date: December 1, 2021
Phase: Phase 3
Study type: Interventional

This study aims to investigate efficacy of intralesional PRP in treatment of finer nail onychomycosis.

NCT ID: NCT03171584 Not yet recruiting - Clinical trials for Antifungal Drugs in Onychomycosis

Antifungal Drugs in Treatment of Onychomycosis

Start date: July 1, 2017
Phase: Phase 3
Study type: Interventional

Onychomycosis refers to the fungal infection of the fingernails or toenails, caused by dermatophytes, yeast and non-dermatophyte molds that lead to distortion, discoloration, thickening and detachment from the nail bed

NCT ID: NCT03098342 Not yet recruiting - Clinical trials for Onychomycosis of Toenail

Comparison of Efficacy and Safety Between Methylene Blue-mediated Photodynamic Therapy and 5% Amorolfine Nail Lacquer for Toenail Onychomycosis Treatment

Start date: June 1, 2017
Phase: N/A
Study type: Interventional

Study centre and address King Chulalongkorn Memorial Hospital Primary objective To compare the efficacy and the safety of methylene blue-mediated photodynamic therapy and 5% amorolfine nail lacquer for toenail onychomycosis in Asians